US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Cambria Global Asset Allocation ETF

34.35

+0.48071.42%

Post-market: 34.35-0.0050-0.01%16:10 EST

Volume:5.05K

Turnover:173.14K

Market Cap:66.12M

PE:- -

High:34.41

Open:34.18

Low:34.08

Close:33.87

52wk High:35.35

52wk Low:26.80

Shares:1.93M

Float Shares:1.93M

Volume Ratio:0.66

T/O Rate:0.26%

Dividend:1.38

Dividend Rate:4.01%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Denali Therapeutics Presents Enzyme TransportVehicle™ Progress Across Three Clinical Programs for Treatment of Lysosomal Storage Disorders at 2026 WORLDSymposium™

What Nova (NVMI)'s Inline Metrology Win in GAA and DRAM Means For Shareholders

Simply Wall St.

Belief BioMed Congratulates Partner AskBio on IND Acceptance by FDA for Investigational Gene Therapy for Late-Onset Pompe Disease

Samsung Unveils World's First 2nm Mobile Chip – Exynos 2600

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/GAA"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GAA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GAA\",,,,,undefined,":{"symbol":"GAA","market":"US","secType":"STK","nameCN":"Cambria Global Asset Allocation ETF","latestPrice":34.35,"timestamp":1770411600000,"preClose":33.8693,"halted":0,"volume":5050,"hourTrading":{"tag":"盘后","latestPrice":34.345,"preClose":34.35,"latestTime":"16:10 EST","volume":7,"amount":240.45,"timestamp":1770412204332,"change":-0.005,"changeRate":-0.000146,"amplitude":0},"delay":0,"changeRate":0.01419279406424103,"floatShares":1925001,"shares":1925001,"eps":0,"marketStatus":"Market Closed","change":0.4807,"latestTime":"02-06 16:00:00 EST","open":34.18,"high":34.41,"low":34.0795,"amount":173136.7278,"amplitude":0.009758,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"CBOE","adjPreClose":33.8693,"sharesOutstanding":1925001,"nav":33.78,"aum":65026533.78,"dividendRate":0.040131,"bidAskSpread":0.002844,"postHourTrading":{"tag":"盘后","latestPrice":34.345,"preClose":34.35,"latestTime":"16:10 EST","volume":7,"amount":240.45,"timestamp":1770412204332,"change":-0.005,"changeRate":-0.000146,"amplitude":0},"volumeRatio":0.6559123179114995},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GAA\",,,,,undefined,":{"symbol":"GAA","floatShares":1925001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.6559123179114995,"shares":1925001,"dividePrice":1.3785,"high":34.41,"amplitude":0.009758,"preClose":33.8693,"low":34.0795,"week52Low":26.8,"pbRate":"--","week52High":35.35,"institutionHeld":0,"latestPrice":34.35,"eps":0,"divideRate":0.040131,"volume":5050,"delay":0,"ttmEps":0,"open":34.18,"prevYearClose":32.5106,"prevWeekClose":34.0242,"prevMonthClose":34.0242,"prevQuarterClose":32.5106,"fiveDayClose":34.0242,"twentyDayClose":32.925,"sixtyDayClose":32.155},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GAA\",params:#limit:5,,,undefined,":[{"date":"2025-12-23","symbol":"GAA","amount":0.40954996,"announcedDate":"2025-12-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-23","defaultRemindTime":1766500200000,"name":"Cambria Global Asset Allocation ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-23","currency":"USD","dateTimestamp":1766466000000,"payDate":"2025-12-24"},{"date":"2025-09-23","symbol":"GAA","amount":0.29146998,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"Cambria Global Asset Allocation ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-24","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-24"},{"date":"2025-06-24","symbol":"GAA","amount":0.24513,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"Cambria Global Asset Allocation ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-25","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-06-25"},{"date":"2025-03-25","symbol":"GAA","amount":0.432705,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"Cambria Global Asset Allocation ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-26","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-03-26"},{"date":"2024-12-23","symbol":"GAA","amount":0.03919674,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-23","defaultRemindTime":1734964200000,"name":"Cambria Global Asset Allocation ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-01-02","payableDate":"2024-12-23","currency":"USD","dateTimestamp":1734930000000,"payDate":"2025-01-02"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GAA\",market:\"US\",,,undefined,":[{"executeDate":"2016-03-29","recordDate":"2016-03-31","paymentDate":"2016-04-07","value":0.0929959,"currency":"USD"},{"executeDate":"2016-06-28","recordDate":"2016-06-30","paymentDate":"2016-07-06","value":0.0842278,"currency":"USD"},{"executeDate":"2016-09-27","recordDate":"2016-09-29","paymentDate":"2016-10-05","value":0.140347,"currency":"USD"},{"executeDate":"2016-12-28","recordDate":"2016-12-30","paymentDate":"2017-01-04","value":0.371232,"currency":"USD"},{"executeDate":"2017-03-29","recordDate":"2017-03-31","paymentDate":"2017-04-07","value":0.071408,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GAA\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GAA\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2609868445","title":"Denali Therapeutics Presents Enzyme TransportVehicle™ Progress Across Three Clinical Programs for Treatment of Lysosomal Storage Disorders at 2026 WORLDSymposium™","url":"https://stock-news.laohu8.com/highlight/detail?id=2609868445","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609868445?lang=en_us&edition=fundamental","pubTime":"2026-02-06 03:00","pubTimestamp":1770318000,"startTime":"0","endTime":"0","summary":"Analysis from continued follow-up of Phase 1/2 clinical trial data in Hunter syndrome (MPS II) reinforces potential for tividenofusp alfa (DNL310) to address full disease spectrumLaunch readiness esta","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/05/3233366/0/en/Denali-Therapeutics-Presents-Enzyme-TransportVehicle-Progress-Across-Three-Clinical-Programs-for-Treatment-of-Lysosomal-Storage-Disorders-at-2026-WORLDSymposium.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GAA","BBB","PRGS","BK4539","LU2065732104.USD","BK4097","BK4139","BK4007","ETV","CNS","LENZ","TV","CSF","BK4100","BK4135"],"gpt_icon":0},{"id":"2608002965","title":"What Nova (NVMI)'s Inline Metrology Win in GAA and DRAM Means For Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2608002965","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608002965?lang=en_us&edition=fundamental","pubTime":"2026-02-01 13:27","pubTimestamp":1769923631,"startTime":"0","endTime":"0","summary":"Nova Ltd. recently announced that its Nova Metrion platform has been adopted by global leaders in Memory and Logic device production for Gate-All-Around and advanced DRAM manufacturing, providing fully automated Secondary Ion Mass Spectrometry for inline process control and full-wafer mapping.\nThis adoption is significant because it moves high-precision materials metrology from the lab into the fab, potentially improving yield by enabling near-real-time monitoring of dopant concentration,...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/8211000-choice2-main-header/1585186947894","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/8211000-choice2-main-header/1585186947894"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/semiconductors/nasdaq-nvmi/nova/news/what-nova-nvmis-inline-metrology-win-in-gaa-and-dram-means-f","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/semiconductors/nasdaq-nvmi/nova/news/what-nova-nvmis-inline-metrology-win-in-gaa-and-dram-means-f","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["DRAM","SG9999000418.SGD","LU0278937759.USD","GAA","BK4147","NVMI"],"gpt_icon":0},{"id":"2603620144","title":"Belief BioMed Congratulates Partner AskBio on IND Acceptance by FDA for Investigational Gene Therapy for Late-Onset Pompe Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2603620144","media":"prnewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603620144?lang=en_us&edition=fundamental","pubTime":"2026-01-15 12:11","pubTimestamp":1768450260,"startTime":"0","endTime":"0","summary":"SHANGHAI, Jan. 15, 2026 /PRNewswire/ -- AskBio Inc. , a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, recently announced that the United States Food and Drug Administration  has accepted its Investigational New Drug  application for AB-1009, an investigational adeno-associated virus  gene therapy being developed for the treatment of late-onset Pompe disease. With this announcement, the AB-1009 program advances to Phase 1/2, and AskBio initiates a clinical trial in the United States to explore the safety of AB-1009. The company anticipates recruiting its first patient in early 2026 [1].In September 2024, Belief BioMed  and AskBio entered astrategic collaboration to explore the potential for new gene therapies [2]. BBM granted AskBio a sublicense to use the proprietary AAV capsid in the AB-1009 program and provided AAV vector production services. Within the collaborative development framework, BBM worked closely with the AskBio team, and its co","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/belief-biomed-congratulates-partner-askbio-on-ind-acceptance-by-fda-for-investigational-gene-therapy-for-late-onset-pompe-disease-302661902.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IND.AU","BK7095","IND","GAA","BLA.AU"],"gpt_icon":0},{"id":"1102156535","title":"Samsung Unveils World's First 2nm Mobile Chip – Exynos 2600","url":"https://stock-news.laohu8.com/highlight/detail?id=1102156535","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102156535?lang=en_us&edition=fundamental","pubTime":"2025-12-21 22:40","pubTimestamp":1766328035,"startTime":"0","endTime":"0","summary":"Samsung has officially launched the Exynos 2600 chip, marking the world's first 2nm mobile processor. Manufactured using Samsung Foundry's 2nm Gate-All-Around (GAA) process, the chip promises...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GAA"],"gpt_icon":0}],"pageSize":4,"totalPage":4,"pageCount":1,"totalSize":15,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/GAA\",params:#limit:6,delay:false,,,undefined,":[]}}